Company / Current Assets per Share
Neurogene Inc. Current Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$18.30
FY2025
5-year range
$3.29 / $24.64
FY2021-FY2025
Trend
-25.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $6.10 to $18.30 over the past 6 years.
Based on SEC 10-K filings.
18.30 in FY2025.
Improved from $6.10 to $18.30 over the past 6 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current assets per share decreased 25.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.30 | -25.7% |
| FY2024 | $24.64 | +303.8% |
| FY2019 | $6.10 | +85.6% |
| FY2018 | $3.29 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026